GNOM vs. WNTR

Last updated Jun 28, 2026

GNOM (Global X Genomics & Biotechnology ETF) and WNTR (YieldMax Short MSTR Option Income Strategy ETF) are both exchange-traded funds - GNOM is a Health & Biotech Equities fund tracking the Solactive Genomics Index, while WNTR is a Derivative Income fund actively managed by YieldMax. GNOM is passively managed, while WNTR is actively managed. Over the past year, GNOM returned 69.62% vs 119.08% for WNTR. At a correlation of -0.33, they often move in opposite directions. GNOM charges 0.50%/yr vs 1.01%/yr for WNTR.

Performance

GNOM vs. WNTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X Genomics & Biotechnology ETF (GNOM) and YieldMax Short MSTR Option Income Strategy ETF (WNTR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GNOM achieves a 23.79% return, which is significantly higher than WNTR's 20.79% return.

GNOM

• 1D: 2.39%
• 1M: 13.26%
• YTD: 23.79%
• 6M: 20.74%
• 1Y: 69.62%
• 3Y*: 5.90%
• 5Y*: -9.86%
• 10Y*: —

WNTR

• 1D: 2.67%
• 1M: 50.71%
• YTD: 20.79%
• 6M: 24.49%
• 1Y: 119.08%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GNOM vs. WNTR - Yearly Performance Comparison

	2026 (YTD)	2025
GNOM Global X Genomics & Biotechnology ETF	23.79%	36.02%
WNTR YieldMax Short MSTR Option Income Strategy ETF	20.79%	52.78%

Correlation

The correlation between GNOM and WNTR is -0.30, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.30
Correlation (All Time) Calculated using the full available price history since Mar 27, 2025	-0.33

Return for Risk

GNOM vs. WNTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GNOM

GNOM Risk / Return Rank: 81
GNOM Sharpe Ratio Rank: 89
GNOM Sortino Ratio Rank: 86
GNOM Omega Ratio Rank: 76
GNOM Calmar Ratio Rank: 82
GNOM Martin Ratio Rank: 69

WNTR

WNTR Risk / Return Rank: 64
WNTR Sharpe Ratio Rank: 81
WNTR Sortino Ratio Rank: 61
WNTR Omega Ratio Rank: 64
WNTR Calmar Ratio Rank: 65
WNTR Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNOM vs. WNTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and YieldMax Short MSTR Option Income Strategy ETF (WNTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GNOM	WNTR	Difference
Sharpe ratio: Return per unit of total volatility	2.55	2.28	+0.27
Sortino ratio: Return per unit of downside risk	3.39	2.52	+0.88
Omega ratio: Gain probability vs. loss probability	1.39	1.34	+0.05
Calmar ratio: Return relative to maximum drawdown	3.85	2.84	+1.02
Martin ratio: Return relative to average drawdown	11.06	7.26	+3.81

GNOM vs. WNTR - Sharpe Ratio Comparison

The current GNOM Sharpe Ratio is 2.55, which is comparable to the WNTR Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of GNOM and WNTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

GNOM vs. WNTR - Drawdown Comparison

The maximum GNOM drawdown since its inception was -75.00%, which is greater than WNTR's maximum drawdown of -42.65%. Use the drawdown chart below to compare losses from any high point for GNOM and WNTR.

Drawdown Indicators

	GNOM	WNTR	Difference
Max Drawdown Largest peak-to-trough decline	-75.00%	-42.65%	-32.35%
Max Drawdown (1Y) Largest decline over 1 year	-18.17%	-42.65%	+24.48%
Max Drawdown (3Y) Largest decline over 3 years	-44.24%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-72.29%	—	—
Current Drawdown Current decline from peak	-48.85%	-1.46%	-47.39%
Average Drawdown Average peak-to-trough decline	-40.65%	-20.81%	-19.84%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.32%	16.66%	-10.34%

Volatility

GNOM vs. WNTR - Volatility Comparison

The current volatility for Global X Genomics & Biotechnology ETF (GNOM) is 9.80%, while YieldMax Short MSTR Option Income Strategy ETF (WNTR) has a volatility of 18.15%. This indicates that GNOM experiences smaller price fluctuations and is considered to be less risky than WNTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GNOM	WNTR	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.80%	18.15%	-8.35%
Volatility (6M) Calculated over the trailing 6-month period	20.69%	46.38%	-25.69%
Volatility (1Y) Calculated over the trailing 1-year period	27.48%	53.11%	-25.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.71%	53.27%	-19.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.18%	53.27%	-19.09%

GNOM vs. WNTR - Expense Ratio Comparison

GNOM has a 0.50% expense ratio, which is lower than WNTR's 1.01% expense ratio.

Dividends

GNOM vs. WNTR - Dividend Comparison

GNOM's dividend yield for the trailing twelve months is around 1.11%, less than WNTR's 91.89% yield.

Position	TTM	2025	2024	2023	2022	2021	2020
GNOM Global X Genomics & Biotechnology ETF	1.05%	1.37%	0.00%	0.00%	0.00%	0.03%	0.14%
WNTR YieldMax Short MSTR Option Income Strategy ETF	91.89%	58.56%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both GNOM and WNTR in my portfolio?

GNOM and WNTR have a correlation of -0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GNOM or WNTR?

WNTR has higher volatility (18.15%) compared to GNOM (9.80%). In terms of maximum drawdown, GNOM dropped -75.00% vs WNTR's -42.65%.

Which ETF is better, GNOM or WNTR?

On 1-year performance, WNTR leads with 119.08% vs 69.62% for GNOM. On fees, GNOM is cheaper at 0.50% per year. On volatility, GNOM has been the lower-risk option at 9.80%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GNOM or WNTR?

Over the 1-year period, WNTR has performed better with a 119.08% return vs 69.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GNOM or WNTR?

GNOM is cheaper with a 0.50% expense ratio, compared with 1.01% for WNTR.

Which ETF pays a higher dividend yield, GNOM or WNTR?

WNTR has the higher dividend yield at 91.89%, compared with 1.05% for GNOM.

What is the main difference between GNOM and WNTR?

GNOM is categorized as Health & Biotech Equities, while WNTR is Derivative Income. They also come from different issuers: Global X and YieldMax. Their fees differ too: 0.50% for GNOM and 1.01% for WNTR.

Which has better risk-adjusted returns?

GNOM currently has the higher Sharpe Ratio (2.55 vs 2.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.